Angina remains one of the most common and important clinical syndromes in cardiovascular practice, reflecting an imbalance between myocardial oxygen supply and demand. The Angina session examines how clinicians can differentiate typical and atypical chest pain, evaluate underlying coronary artery disease, and tailor treatment to relieve symptoms while improving long-term outcomes. Participants will review the spectrum from stable angina and microvascular disease to acute coronary syndromes, with an emphasis on structured diagnostic pathways that integrate clinical assessment, biomarkers, and noninvasive imaging.

As patients increasingly research options for an cardiology conference to better understand modern care, clinicians need up-to-date knowledge on when to rely on medical therapy, when to order advanced imaging, and when to refer for revascularization. This session outlines contemporary evaluation strategies including stress testing, CT coronary angiography, and functional assessments such as FFR or iFR. Attendees will see how guideline-directed medical therapy—encompassing antianginal drugs, antiplatelet agents, lipid-lowering therapy, and risk-factor control—can be combined with lifestyle interventions to reduce events and enhance quality of life. Special attention is paid to populations with diagnostic challenges, including women, patients with diabetes, and those with non-obstructive coronary arteries but persistent ischemic symptoms.

A key discussion point is the relationship between angina and chronic coronary syndrome, highlighting how stable symptom patterns can still carry significant risk if not addressed comprehensively. Participants will learn how to communicate risk effectively, involve patients in shared decision-making, and select between invasive and noninvasive strategies based on anatomical and functional data. Case examples will illustrate the management of multi-vessel disease, left main involvement, and high-risk anatomical subsets, showing how multidisciplinary heart teams approach complex choices.

The session also emphasizes long-term follow-up, adherence counseling, and integration with cardiac rehabilitation. Strategies for managing residual angina after PCI or CABG, addressing comorbidities such as heart failure or arrhythmias, and supporting patients with psychosocial stressors are woven throughout. By the end, attendees will be equipped with a practical, patient-centered approach to diagnosing and managing angina across a wide range of clinical settings.